Review of the monarchE trial suggests no evidence to support use of adjuvant abemaciclib in women with breast cancer.

Meirson, Tomer; Goldstein, Daniel A; Gyawali, Bishal; Tannock, Ian F

Meirson, Tomer; Goldstein, Daniel A; Gyawali, Bishal; Tannock, Ian F.

Afiliação

Meirson T; Davidoff Cancer Center, Rabin Medical Center, Petach Tikvah, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Goldstein DA; Davidoff Cancer Center, Rabin Medical Center, Petach Tikvah, Israel; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Clalit Health Service, Tel Aviv, Israel; Optimal Cancer Care Alliance, Ann Arbor, MI, USA.
Gyawali B; Division of Cancer Care and Epidemiology & Departments of Oncology and Public Health Sciences, Queen's University Cancer Research Institute, Kingston, ON, Canada.
Tannock IF; Optimal Cancer Care Alliance, Ann Arbor, MI, USA; Division of Medical Oncology, Princess Margaret Cancer Centre, Toronto, ON M5G 2M9, Canada. Electronic address: ian.tannock@uhn.ca.

Lancet Oncol ; 24(6): 589-593, 2023 06.

Article em En | MEDLINE | ID: mdl-37146621

Assuntos

Neoplasias da Mama; Feminino; Humanos; Neoplasias da Mama/tratamento farmacológico; Aminopiridinas/efeitos adversos; Benzimidazóis/efeitos adversos; Protocolos de Quimioterapia Combinada Antineoplásica/efeitos adversos; Receptor ErbB-2

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Limite: Female / Humans Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Israel

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google